{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:53:12Z","timestamp":1777942392787,"version":"3.51.4"},"reference-count":205,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Hepatocellular carcinoma (HCC) represents the second leading cause of cancer mortality worldwide and is mostly caused by hepatitis B virus (HBV) infection. HBV can induce HCC by an indirect mechanism of continuous necro-inflammation, contributing to hepatocyte damage and promoting cancer, as well as by viral intrinsic factors. Among them, the major contributors to the development of HBV-related HCC are represented by (i) HBV DNA integration in genes modulating cell proliferation, (ii) HBV pro-oncogenic proteins, such as HBx and HBs, and (iii) the accumulation of viral mutations, enhancing the tumorigenic features of HBV proteins. The currently available antiviral treatments, based on the usage of Nucleos(t)ide analogs (NUCs), substantially control HBV replication. However, even a successful NUC treatment does not completely abrogate HCC risk, since it rarely allows achievement of an HBV functional cure, the therapeutic end-point associated with HBsAg loss and more favorable liver outcomes. To date, novel therapeutic strategies based on innovative direct antivirals (nucleic acid polymers, small interfering RNAs, antisense oligonucleotides, covalently closed circular DNA (cccDNA) inhibitors, and capsid assembly modulators) and immune-therapeutics (therapeutic vaccines, checkpoint inhibitors, and Toll-like receptor agonists) are under evaluation in clinical trials. These approaches are showing promising data in terms of an HBV functional cure, thus representing novel strategies that could be beneficial for reducing the burden of HBV-related HCC. Lastly, further efforts in drug development are necessary to identify new compounds that could achieve a sterilizing HBV cure, implying the complete elimination of cccDNA and integrated HBV DNA, the only end-point that completely eradicates HBV and its related oncogenic risk.<\/jats:p>","DOI":"10.3390\/v18020185","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T16:08:17Z","timestamp":1769702897000},"page":"185","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Direct Viral Mechanisms Underlying the Onset of HBV-Related Hepatocellular Carcinoma and Implications for Therapeutic Strategies"],"prefix":"10.3390","volume":"18","author":[{"given":"Simone","family":"La Frazia","sequence":"first","affiliation":[{"name":"Department of Biology, University of Rome Tor Vergata, Via della Ricerca Scientifica, 1, 00133 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia","family":"Magnapera","sequence":"additional","affiliation":[{"name":"Department of Biology, University of Rome Tor Vergata, Via della Ricerca Scientifica, 1, 00133 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3500-0858","authenticated-orcid":false,"given":"Lorenzo","family":"Piermatteo","sequence":"additional","affiliation":[{"name":"Department of Biology, University of Rome Tor Vergata, Via della Ricerca Scientifica, 1, 00133 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9334-8582","authenticated-orcid":false,"given":"Stefano","family":"D\u2019Anna","sequence":"additional","affiliation":[{"name":"Department of Biology, University of Rome Tor Vergata, Via della Ricerca Scientifica, 1, 00133 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2970-2037","authenticated-orcid":false,"given":"Leonardo","family":"Duca","sequence":"additional","affiliation":[{"name":"Laboratory of Electron Microscopy, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Viale Portuense 292, 00149 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Svicher","sequence":"additional","affiliation":[{"name":"Department of Biology, University of Rome Tor Vergata, Via della Ricerca Scientifica, 1, 00133 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romina","family":"Salpini","sequence":"additional","affiliation":[{"name":"Department of Biology, University of Rome Tor Vergata, Via della Ricerca Scientifica, 1, 00133 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,29]]},"reference":[{"key":"ref_1","unstructured":"(2026, January 13). International Agency for Research on Cancer (IARC) Global Cancer Observatory: Cancer Today, IARC, Lyon. Available online: https:\/\/gco.iarc.who.int\/."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","article-title":"Global Burden of Primary Liver Cancer in 2020 and Predictions to 2040","volume":"77","author":"Rumgay","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41392-024-02072-z","article-title":"Liver Diseases: Epidemiology, Causes, Trends and Predictions","volume":"10","author":"Gan","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s12072-024-10699-x","article-title":"Dual-Etiology MAFLD: The Interactions between Viral Hepatitis B, Viral Hepatitis C, Alcohol, and MAFLD","volume":"18","author":"Liu","year":"2024","journal-title":"Hepatol. Int."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/jvh.13862","article-title":"Impact of Prior HBV, HAV, and HEV Infection on Non-Alcoholic Fatty Liver Disease","volume":"30","author":"Vassilopoulos","year":"2023","journal-title":"J. Viral Hepat."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1002\/ijc.31280","article-title":"Fraction and Incidence of Liver Cancer Attributable to Hepatitis B and C Viruses Worldwide","volume":"142","author":"Franceschi","year":"2018","journal-title":"Int. J. Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1001\/jamaoncol.2017.3055","article-title":"The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level: Results From the Global Burden of Disease Study 2015","volume":"3","author":"Fitzmaurice","year":"2017","journal-title":"JAMA Oncol."},{"key":"ref_8","first-page":"394","article-title":"Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"127","DOI":"10.17998\/jlc.2022.12.30","article-title":"Non-Alcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma","volume":"23","author":"Daher","year":"2023","journal-title":"J. Liver Cancer"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s11901-020-00534-w","article-title":"Targeting Viral CccDNA for Cure of Chronic Hepatitis B","volume":"19","author":"Ligat","year":"2020","journal-title":"Curr. Hepatol. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrc3449","article-title":"Pathogenic Mechanisms in HBV- and HCV-Associated Hepatocellular Carcinoma","volume":"13","author":"Arzumanyan","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.cgh.2013.04.043","article-title":"Synergistic Effects of Family History of Hepatocellular Carcinoma and Hepatitis B Virus Infection on Risk for Incident Hepatocellular Carcinoma","volume":"11","author":"Loomba","year":"2013","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1200\/JCO.2009.26.2675","article-title":"Clinical Scoring System to Predict Hepatocellular Carcinoma in Chronic Hepatitis B Carriers","volume":"28","author":"Wong","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e70049","DOI":"10.1111\/jvh.70049","article-title":"Recognisable Alcohol Use Significantly Increases the Risk of Adverse Outcomes in Patients With Hepatitis B Virus-Related Cirrhosis","volume":"32","author":"Hui","year":"2025","journal-title":"J. Viral Hepat."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"7213","DOI":"10.3748\/wjg.v20.i23.7213","article-title":"Association between Metabolic Factors and Chronic Hepatitis B Virus Infection","volume":"20","author":"Chiang","year":"2014","journal-title":"World J. Gastroenterol. WJG"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1016\/j.cgh.2023.02.004","article-title":"Diabetes Mellitus Impacts on the Performance of Hepatocellular Carcinoma Risk Scores in Chronic Hepatitis B Patients","volume":"21","author":"Yip","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1515\/BC.2009.111","article-title":"Mechanisms of Liver Disease: The Crosstalk between the NF-\u039aB and JNK Pathways","volume":"390","author":"Papa","year":"2009","journal-title":"Biol. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s12964-024-01619-5","article-title":"Metabolic Self-Feeding in HBV-Associated Hepatocarcinoma Centered on Feedback between Circulation Lipids and the Cellular MAPK\/MTOR Axis","volume":"22","author":"Zhu","year":"2024","journal-title":"Cell Commun. Signal"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s12072-023-10545-6","article-title":"Distinct Effects of Hepatic Steatosis and Metabolic Dysfunction on the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B","volume":"17","author":"Huang","year":"2023","journal-title":"Hepatol. Int."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"18027","DOI":"10.1038\/s41598-025-03244-9","article-title":"Impact of Metabolic Dysfunction-Associated Fatty Liver Disease on Survival Outcomes in Patients Undergoing Radical Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma","volume":"15","author":"Xiong","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jhep.2008.07.023","article-title":"Independent Risk Factors and Predictive Score for the Development of Hepatocellular Carcinoma in Chronic Hepatitis B","volume":"50","author":"Yuen","year":"2009","journal-title":"J. Hepatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/cncr.30246","article-title":"Impact of Country of Birth on the Age of Diagnosis of Hepatocellular Carcinoma in the United States","volume":"123","author":"Yang","year":"2016","journal-title":"Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.17998\/jlc.2024.08.03","article-title":"Disease Modifiers and Novel Markers in Hepatitis B Virus-Related Hepatocellular Carcinoma","volume":"24","author":"Mak","year":"2024","journal-title":"J. Liver Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.cgh.2017.08.042","article-title":"Role of Age and Race in the Risk of Hepatocellular Carcinoma in Veterans With Hepatitis B Virus Infection","volume":"16","author":"Mittal","year":"2018","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"9069375","DOI":"10.1155\/2016\/9069375","article-title":"Clinical Relevance of HLA Gene Variants in HBV Infection","volume":"2016","author":"Wang","year":"2016","journal-title":"J. Immunol. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"BSR20190783","DOI":"10.1042\/BSR20190783","article-title":"Association of STAT3 and STAT4 polymorphisms with susceptibility to chronic hepatitis B virus infection and risk of hepatocellular carcinoma: A meta-analysis","volume":"39","author":"Shi","year":"2019","journal-title":"Biosci. Rep."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41588-020-0640-3","article-title":"Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases","volume":"52","author":"Ishigaki","year":"2020","journal-title":"Nat. Genet."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJMra1001683","article-title":"Hepatocellular Carcinoma","volume":"365","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1349-7006.2006.00235.x","article-title":"Hepatitis B Virus Pre-S Mutants, Endoplasmic Reticulum Stress and Hepatocarcinogenesis","volume":"97","author":"Wang","year":"2006","journal-title":"Cancer Sci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1074\/jbc.M708419200","article-title":"Interaction of Hepatitis B Viral Oncoprotein with Cellular Target HBXIP Dysregulates Centrosome Dynamics and Mitotic Spindle Formation","volume":"283","author":"Wen","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jhep.2014.04.041","article-title":"Hepatitis B Virus PreS\/S Gene Variants: Pathobiology and Clinical Implications","volume":"61","author":"Pollicino","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"792","DOI":"10.3892\/or.2014.3647","article-title":"HBx Protein-Induced Upregulation of MicroRNA-221 Promotes Aberrant Proliferation in HBV-related Hepatocellular Carcinoma by Targeting Estrogen Receptor-\u03b1","volume":"33","author":"Chen","year":"2015","journal-title":"Oncol. Rep."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.bbadis.2014.03.007","article-title":"Dysregulation of the TGFBI Gene Is Involved in the Oncogenic Activity of the Nonsense Mutation of Hepatitis B Virus Surface Gene SW182*","volume":"1842","author":"Jiang","year":"2014","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Huang, S.F., Chen, Y.T., Lee, W.C., Chang, I.C., Chiu, Y.T., Chang, Y., Tu, H.C., Yuh, C.H., Matsuura, I., and Shih, L.Y. (2014). Identification of Transforming Hepatitis B Virus S Gene Nonsense Mutations Derived from Freely Replicative Viruses in Hepatocellular Carcinoma. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0089753"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jhep.2009.10.033","article-title":"Mechanisms of HBV-Related Hepatocarcinogenesis","volume":"52","author":"Neuveut","year":"2010","journal-title":"J. Hepatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.canlet.2013.08.035","article-title":"Hepatitis B Virus-Induced Hepatocellular Carcinoma","volume":"345","author":"Xu","year":"2014","journal-title":"Cancer Lett."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Salpini, R., D\u2019Anna, S., Benedetti, L., Piermatteo, L., Gill, U., Svicher, V., and Kennedy, P.T.F. (2022). Hepatitis B Virus DNA Integration as a Novel Biomarker of Hepatitis B Virus-Mediated Pathogenetic Properties and a Barrier to the Current Strategies for Hepatitis B Virus Cure. Front. Microbiol., 13.","DOI":"10.3389\/fmicb.2022.972687"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2147\/JHC.S307962","article-title":"The Mechanisms of HBV-Induced Hepatocellular Carcinoma","volume":"8","author":"Jiang","year":"2021","journal-title":"J. Hepatocell. Carcinoma"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Tu, T., Zhang, H., and Urban, S. (2021). Hepatitis B Virus DNA Integration: In Vitro Models for Investigating Viral Pathogenesis and Persistence. Viruses, 13.","DOI":"10.3390\/v13020180"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.livres.2025.09.002","article-title":"Hepatitis B Virus Integration and Hepatocarcinogenesis","volume":"9","author":"Ma","year":"2025","journal-title":"Liver Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1111\/jgh.14075","article-title":"Integration of Hepatitis B Virus S Gene Impacts on Hepatitis B Surface Antigen Levels in Patients with Antiviral Therapy","volume":"33","author":"Hu","year":"2018","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"101","DOI":"10.5009\/gnl.2007.1.2.101","article-title":"Molecular Pathogenesis of Hepatitis-B-Virus-Associated Hepatocellular Carcinoma","volume":"1","author":"Park","year":"2007","journal-title":"Gut Liver"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1053\/j.gastro.2004.09.014","article-title":"Hepatocellular Carcinoma in Cirrhosis: Incidence and Risk Factors","volume":"127","author":"Fattovich","year":"2004","journal-title":"Gastroenterology"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1002\/hep.22898","article-title":"The Natural History of Chronic Hepatitis B Virus Infection","volume":"49","author":"McMahon","year":"2009","journal-title":"Hepatology"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2011.12.061","article-title":"Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma","volume":"142","year":"2012","journal-title":"Gastroenterology"},{"key":"ref_46","unstructured":"(2025, July 29). Clinical Practice Guidelines Archives\u2014EASL-The Home of Hepatology. Available online: https:\/\/easl.eu\/publication-category\/clinical-practice-guidelines\/."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.295.1.65","article-title":"Risk of Hepatocellular Carcinoma across a Biological Gradient of Serum Hepatitis B Virus DNA Level","volume":"295","author":"Chen","year":"2006","journal-title":"JAMA"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1053\/j.gastro.2005.11.016","article-title":"Predicting Cirrhosis Risk Based on the Level of Circulating Hepatitis B Viral Load","volume":"130","author":"Iloeje","year":"2006","journal-title":"Gastroenterology"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1016\/j.jhep.2016.02.021","article-title":"Mechanisms of HBV-Induced Hepatocellular Carcinoma","volume":"64","author":"Levrero","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Yu, H., Yuan, Q., Ge, S.X., Wang, H.Y., Zhang, Y.L., Chen, Q.R., Zhang, J., Chen, P.J., and Xia, N.S. (2010). Molecular and Phylogenetic Analyses Suggest an Additional Hepatitis B Virus Genotype \u201cI\u201d. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0009297"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1016\/j.vaccine.2004.10.045","article-title":"Hepatitis B Virus Genotypes","volume":"23","author":"Kramvis","year":"2005","journal-title":"Vaccine"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000080872","article-title":"Genetic Diversity of Hepatitis B Virus Strains Derived Worldwide: Genotypes, Subgenotypes, and HBsAg Subtypes","volume":"47","author":"Norder","year":"2004","journal-title":"Intervirology"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.jhep.2017.07.011","article-title":"How Viral Genetic Variants and Genotypes Influence Disease and Treatment Outcome of Chronic Hepatitis B. Time for an Individualised Approach?","volume":"67","author":"Rajoriya","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.cgh.2009.08.004","article-title":"Hepatitis B Virus Genotype C Is Associated With More Severe Liver Fibrosis Than Genotype B","volume":"7","author":"Chan","year":"2009","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s00535-010-0253-1","article-title":"Significant Association of Different PreS Mutations with Hepatitis B-Related Cirrhosis or Hepatocellular Carcinoma","volume":"45","author":"Yin","year":"2010","journal-title":"J. Gastroenterol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1136\/gut.2003.033324","article-title":"Genotype C Hepatitis B Virus Infection Is Associated with an Increased Risk of Hepatocellular Carcinoma","volume":"53","author":"Chan","year":"2004","journal-title":"Gut"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/jnci\/dji043","article-title":"Hepatitis B Virus Genotype and DNA Level and Hepatocellular Carcinoma: A Prospective Study in Men","volume":"97","author":"Yu","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1046\/j.1440-1746.2002.02737.x","article-title":"Hepatitis B Viral Genotypes: Clinical Relevance and Molecular Characteristics","volume":"17","author":"Kao","year":"2002","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e70008","DOI":"10.1111\/jvh.70008","article-title":"Long-Term Outcome of Chronic Hepatitis B-Histological Score and Viral Genotype Are Important Predictors of Hepatocellular Carcinoma","volume":"32","author":"Eilard","year":"2025","journal-title":"J. Viral Hepat."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.4254\/wjh.v13.i12.1875","article-title":"Genotype E: The Neglected Genotype of Hepatitis B Virus","volume":"13","author":"Ingasia","year":"2021","journal-title":"World J. Hepatol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1002\/hep.32065","article-title":"HBV Genotype: A Significant Risk Factor in Determining Which Patients With Chronic HBV Infection Should Undergo Surveillance for HCC: The Hepatitis B Alaska Study","volume":"74","author":"McMahon","year":"2021","journal-title":"Hepatology"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"7181","DOI":"10.3748\/wjg.v20.i23.7181","article-title":"Hepatitis B Virus Infection in Latin America: A Genomic Medicine Approach","volume":"20","author":"Roman","year":"2014","journal-title":"World J. Gastroenterol. WJG"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"La Frazia, S., Pauciullo, S., Zulian, V., and Garbuglia, A.R. (2024). Viral Oncogenesis: Synergistic Role of Genome Integration and Persistence. Viruses, 16.","DOI":"10.3390\/v16121965"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1128\/MCB.01189-12","article-title":"Altered Binding Site Selection of P53 Transcription Cassettes by Hepatitis B Virus X Protein","volume":"33","author":"Chan","year":"2013","journal-title":"Mol. Cell Biol."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Sivasudhan, E., Blake, N., Lu, Z., Meng, J., and Rong, R. (2022). Hepatitis B Viral Protein HBx and the Molecular Mechanisms Modulating the Hallmarks of Hepatocellular Carcinoma: A Comprehensive Review. Cells, 11.","DOI":"10.3390\/cells11040741"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"713","DOI":"10.2147\/JHC.S384751","article-title":"Molecular and Clinical Features of Hepatocellular Carcinoma in Patients with HBV-HDV Infection","volume":"10","author":"Costante","year":"2023","journal-title":"J. Hepatocell. Carcinoma"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1349-7006.2006.00299.x","article-title":"Molecular Functions and Biological Roles of Hepatitis B Virus x Protein","volume":"97","author":"Tang","year":"2006","journal-title":"Cancer Sci."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Wang, F., Song, H., Xu, F., Xu, J., Wang, L., Yang, F., Zhu, Y., and Tan, G. (2023). Role of Hepatitis B Virus Non-Structural Protein HBx on HBV Replication, Interferon Signaling, and Hepatocarcinogenesis. Front. Microbiol., 14.","DOI":"10.3389\/fmicb.2023.1322892"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1158\/1078-0432.CCR-07-5082","article-title":"COOH-Terminal Truncated HBV X Protein Plays Key Role in Hepatocarcinogenesis","volume":"14","author":"Ma","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Chau, D.K.f., Chen, G.G., Zhang, H., Leung, B.C.S., Chun, S., and Lai, P.B.S. (2012). Differential Functions of C- and N-Terminal Hepatitis B x Protein in Liver Cells Treated with Doxorubicin in Normoxic or Hypoxic Condition. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0050118"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"5771","DOI":"10.1158\/0008-5472.CAN-07-0529","article-title":"Expression of DNA Methyltransferase 1 Is Activated by Hepatitis B Virus X Protein via a Regulatory Circuit Involving the P16INK4a-Cyclin D1-CDK 4\/6-PRb-E2F1 Pathway","volume":"67","author":"Jin","year":"2007","journal-title":"Cancer Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/s41598-020-57637-z","article-title":"HBV X Protein Mutations Affect HBV Transcription and Association of Histone-Modifying Enzymes with Covalently Closed Circular DNA","volume":"10","author":"Chong","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.canlet.2005.07.009","article-title":"Parallel Epigenetic and Genetic Changes in the Pathogenesis of Hepatitis Virus-Associated Hepatocellular Carcinoma","volume":"239","author":"Feitelson","year":"2006","journal-title":"Cancer Lett."},{"key":"ref_74","first-page":"182","article-title":"Hepatitis B Virus X Protein Accelerates the Development of Hepatoma","volume":"11","author":"Zhang","year":"2014","journal-title":"Cancer Biol. Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"10440","DOI":"10.1038\/s41598-017-10570-0","article-title":"Contribution of C1485T Mutation in the HBx Gene to Human and Murine Hepatocarcinogenesis","volume":"7","author":"Hagiwara","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jceh.2012.10.003","article-title":"Molecular Biology of the Hepatitis B Virus for Clinicians","volume":"2","author":"Datta","year":"2012","journal-title":"J. Clin. Exp. Hepatol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1158\/1541-7786.MCR-18-1127","article-title":"HBx-K130M\/V131I Promotes Liver Cancer in Transgenic Mice via AKT\/FOXO1 Signaling Pathway and Arachidonic Acid Metabolism","volume":"17","author":"Chiu","year":"2019","journal-title":"Mol. Cancer Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"105115","DOI":"10.18632\/oncotarget.22428","article-title":"Hepatitis B Virus (HBV) X Gene Mutations and Their Association with Liver Disease Progression in HBV-Infected Patients","volume":"8","author":"Nazir","year":"2017","journal-title":"Oncotarget"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1128\/CVI.00474-10","article-title":"Impact of Hepatitis B Virus (HBV) x Gene Mutations on Hepatocellular Carcinoma Development in Chronic HBV Infection","volume":"18","author":"Lee","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1111\/j.1572-0241.2008.01974.x","article-title":"HBV A1762T, G1764A Mutations Are a Valuable Biomarker for Identifying a Subset of Male HBsAg Carriers at Extremely High Risk of Hepatocellular Carcinoma: A Prospective Study","volume":"103","author":"Fang","year":"2008","journal-title":"Am. J. Gastroenterol."},{"key":"ref_81","first-page":"OC31","article-title":"Mutations in Hepatitis-B X-Gene Region: Chronic Hepatitis-B versus Cirrhosis","volume":"11","author":"Salarnia","year":"2017","journal-title":"J. Clin. Diagn. Res."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Shoraka, S., Hosseinian, S.M., Hasibi, A., Ghaemi, A., and Mohebbi, S.R. (2023). The Role of Hepatitis B Virus Genome Variations in HBV-Related HCC: Effects on Host Signaling Pathways. Front. Microbiol., 14.","DOI":"10.3389\/fmicb.2023.1213145"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"An, P., Xu, J., Yu, Y., and Winkler, C.A. (2018). Host and Viral Genetic Variation in HBV-Related Hepatocellular Carcinoma. Front. Genet., 9.","DOI":"10.3389\/fgene.2018.00261"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.3748\/wjg.14.1346","article-title":"COOH-Terminal Deletion of HBx Gene Is a Frequent Event in HBV-Associated Hepatocellular Carcinoma","volume":"14","author":"Liu","year":"2008","journal-title":"World J. Gastroenterol. WJG"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Pu, R., Liu, W., Zhou, X., Chen, X., Hou, X., Cai, S., Chen, L., Wu, J., Yang, F., and Tan, X. (2022). The Effects and Underlying Mechanisms of Hepatitis B Virus X Gene Mutants on the Development of Hepatocellular Carcinoma. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.836517"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1055\/s-0029-1210921","article-title":"Decreased Plasma C-Peptide to Insulin Molar Ratio after Oral Glucose in Elderly Subjects","volume":"94","author":"Ikeda","year":"1989","journal-title":"Exp. Clin. Endocrinol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1111\/j.1440-1746.1997.tb00499.x","article-title":"Molecular Biology of Hepatitis B Virus e Antigen","volume":"12","author":"Ou","year":"1997","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"7644","DOI":"10.3748\/wjg.v20.i24.7644","article-title":"HBeaG Negative Variants and Their Role in the Natural History of Chronic Hepatitis B Virus Infection","volume":"20","author":"Alexopoulou","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"708","DOI":"10.4254\/wjh.v14.i4.708","article-title":"Review on Hepatitis B Virus Precore\/Core Promoter Mutations and Their Correlation with Genotypes and Liver Disease Severity","volume":"14","author":"Kumar","year":"2022","journal-title":"World J. Hepatol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"e6835","DOI":"10.1097\/MD.0000000000006835","article-title":"The Association between Hepatitis B Mutants and Hepatocellular Carcinoma: A Meta-Analysis","volume":"96","author":"Wei","year":"2017","journal-title":"Medicine"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.virs.2023.06.004","article-title":"HBV Precore G1896A Mutation Promotes Growth of Hepatocellular Carcinoma Cells by Activating ERK\/MAPK Pathway","volume":"38","author":"Zhao","year":"2023","journal-title":"Virol. Sin."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Kim, D.W., Lee, S.A., Hwang, E.S., Kook, Y.H., and Kim, B.J. (2012). Naturally Occurring Precore\/Core Region Mutations of Hepatitis B Virus Genotype C Related to Hepatocellular Carcinoma. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0047372"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Malik, A., Singhal, D.K., Albanyan, A., Husain, S.A., and Kar, P. (2012). Hepatitis B Virus Gene Mutations in Liver Diseases: A Report from New Delhi. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0039028"},{"key":"ref_94","unstructured":"Howley, P.M., and Knipe, D.M. (2021). Hepadnaviridae. Fields Virology: DNA Viruses, Kluwer Wolters. [7th ed.]."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1083\/jcb.118.6.1305","article-title":"Hepatitis B Surface Antigen Assembles in a Post-ER, Pre-Golgi Compartment","volume":"118","author":"Huovila","year":"1992","journal-title":"J. Cell Biol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/0092-8674(89)90770-8","article-title":"Molecular Pathogenesis of Hepatocellular Carcinoma in Hepatitis B Virus Transgenic Mice","volume":"59","author":"Chisari","year":"1989","journal-title":"Cell"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"15704","DOI":"10.18632\/oncotarget.14944","article-title":"Novel HBsAg Mutations Correlate with Hepatocellular Carcinoma, Hamper HBsAg Secretion and Promote Cell Proliferation in Vitro","volume":"8","author":"Salpini","year":"2017","journal-title":"Oncotarget"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/path.4531","article-title":"Hepatitis B Virus Pre-S2 Mutant Large Surface Protein Inhibits DNA Double-Strand Break Repair and Leads to Genome Instability in Hepatocarcinogenesis","volume":"236","author":"Hsieh","year":"2015","journal-title":"J. Pathol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1128\/jvi.68.5.3193-3199.1994","article-title":"Hepatitis B Virus RNA Element That Facilitates Accumulation of Surface Gene Transcripts in the Cytoplasm","volume":"68","author":"Huang","year":"1994","journal-title":"J. Virol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1128\/jvi.70.1.133-140.1996","article-title":"Intracellular Retention of Surface Protein by a Hepatitis B Virus Mutant That Releases Virion Particles","volume":"70","author":"Xu","year":"1996","journal-title":"J. Virol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"5449","DOI":"10.1128\/JCM.41.12.5449-5455.2003","article-title":"High Prevalence of Hepatitis B Virus Pre-S Mutant in Countries Where It Is Endemic and Its Relationship with Genotype and Chronicity","volume":"41","author":"Huy","year":"2003","journal-title":"J. Clin. Microbiol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/nature02119","article-title":"Altered Thymic T-Cell Selection Due to a Mutation of the ZAP-70 Gene Causes Autoimmune Arthritis in Mice","volume":"426","author":"Sakaguchi","year":"2003","journal-title":"Nature"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1423-0127-16-84","article-title":"A Pre-S Gene Chip to Detect Pre-S Deletions in Hepatitis B Virus Large Surface Antigen as a Predictive Marker for Hepatoma Risk in Chronic Hepatitis B Virus Carriers","volume":"16","author":"Shen","year":"2009","journal-title":"J. Biomed. Sci."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Lin, Y.T., Jeng, L.B., Chan, W.L., Su, I.J., and Teng, C.F. (2021). Hepatitis B Virus Pre-S Gene Deletions and Pre-S Deleted Proteins: Clinical and Molecular Implications in Hepatocellular Carcinoma. Viruses, 13.","DOI":"10.3390\/v13050862"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1177\/0146167206298568","article-title":"Individual Differences in Analytic versus Holistic Thinking","volume":"33","author":"Choi","year":"2007","journal-title":"Pers. Soc. Psychol. Bull."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.cell.2008.07.048","article-title":"Identification of a Lipokine, a Lipid Hormone Linking Adipose Tissue to Systemic Metabolism","volume":"134","author":"Cao","year":"2008","journal-title":"Cell"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1111\/cdev.12096","article-title":"Developmental Changes in Executive Functioning","volume":"84","author":"Lee","year":"2013","journal-title":"Child. Dev."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1128\/jvi.65.7.3813-3820.1991","article-title":"Mutational Analysis of Hepatitis B Surface Antigen Particle Assembly and Secretion","volume":"65","author":"Bruss","year":"1991","journal-title":"J. Virol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12985-018-0972-0","article-title":"The Truncated Mutant HBsAg Expression Increases the Tumorigenesis of Hepatitis B Virus by Regulating TGF-\u03b2\/Smad Signaling Pathway","volume":"15","author":"Wang","year":"2018","journal-title":"Virol. J."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jhep.2011.06.028","article-title":"Nucleotide Change of Codon 182 in the Surface Gene of Hepatitis B Virus Genotype C Leading to Truncated Surface Protein Is Associated with Progression of Liver Diseases","volume":"56","author":"Lee","year":"2012","journal-title":"J. Hepatol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.virol.2016.11.007","article-title":"Stop Codons in the Hepatitis B Surface Proteins Are Enriched during Antiviral Therapy and Are Associated with Host Cell Apoptosis","volume":"501","author":"Colledge","year":"2017","journal-title":"Virology"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.jhep.2024.06.037","article-title":"Hepatitis B Virus DNA Integration: Implications for Diagnostics, Therapy, and Outcome","volume":"81","author":"Zoulim","year":"2024","journal-title":"J. Hepatol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s40364-024-00611-y","article-title":"The Impact of Integrated Hepatitis B Virus DNA on Oncogenesis and Antiviral Therapy","volume":"12","author":"Zhang","year":"2024","journal-title":"Biomark. Res."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Tu, T., Budzinska, M.A., Shackel, N.A., and Urban, S. (2017). HBV DNA Integration: Molecular Mechanisms and Clinical Implications. Viruses, 9.","DOI":"10.3390\/v9040075"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1136\/gutjnl-2023-330414","article-title":"HBV Integrations Reshaping Genomic Structures Promote Hepatocellular Carcinoma","volume":"73","author":"Qian","year":"2024","journal-title":"Gut"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1038\/sj.onc.1210279","article-title":"TP53 Mutations and Hepatocellular Carcinoma: Insights into the Etiology and Pathogenesis of Liver Cancer","volume":"26","author":"Hussain","year":"2007","journal-title":"Oncogene"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1136\/gutjnl-2020-323153","article-title":"Hepatitis B Virus Integrations Promote Local and Distant Oncogenic Driver Alterations in Hepatocellular Carcinoma","volume":"71","author":"Imbeaud","year":"2022","journal-title":"Gut"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41525-023-00355-y","article-title":"Characteristics of Hepatitis B Virus Integration and Mechanism of Inducing Chromosome Translocation","volume":"8","author":"Cui","year":"2023","journal-title":"npj Genom. Med."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1136\/gutjnl-2020-323300","article-title":"Whole Exome HBV DNA Integration Is Independent of the Intrahepatic HBV Reservoir in HBeAg-Negative Chronic Hepatitis B","volume":"70","author":"Svicher","year":"2021","journal-title":"Gut"},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Piermatteo, L., Alkhatib, M., D\u2019anna, S., Malagnino, V., Bertoli, A., Andreassi, E., Basile, E., Iuvara, A., De Cristofaro, M., and Cappiello, G. (2021). HBeAg Levels Vary across the Different Stages of HBV Infection According to the Extent of Immunological Pressure and Are Associated with Therapeutic Outcome in the Setting of Immunosuppression-Driven HBV Reactivation. Biomedicines, 9.","DOI":"10.3390\/biomedicines9101352"},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Peng, B., Pan, L., and Li, W. (2024). New Insights on Hepatitis B Virus Viral Transcription in Single Hepatocytes. Viruses, 16.","DOI":"10.3390\/v16121828"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1053\/j.gastro.2016.07.012","article-title":"HBV DNA Integration and Clonal Hepatocyte Expansion in Chronic Hepatitis B Patients Considered Immune Tolerant","volume":"151","author":"Mason","year":"2016","journal-title":"Gastroenterology"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2147\/HMER.S526977","article-title":"Historical and Emerging Trends in Hepatitis B Virus Integration: A Bibliometric Visual Analysis","volume":"17","author":"Liu","year":"2025","journal-title":"Hepat. Med."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jhep.2015.09.013","article-title":"Hepatitis B Virus-Human Chimeric Transcript HBx-LINE1 Promotes Hepatic Injury via Sequestering Cellular MicroRNA-122","volume":"64","author":"Liang","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/hep.31231","article-title":"Hepatitis B Virus-Telomerase Reverse Transcriptase Promoter Integration Harnesses Host ELF4, Resulting in Telomerase Reverse Transcriptase Gene Transcription in Hepatocellular Carcinoma","volume":"73","author":"Sze","year":"2021","journal-title":"Hepatology"},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Sausen, D.G., Shechter, O., Bietsch, W., Shi, Z., Miller, S.M., Gallo, E.S., Dahari, H., and Borenstein, R. (2022). Hepatitis B and Hepatitis D Viruses: A Comprehensive Update with an Immunological Focus. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232415973"},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Salpini, R., Svicher, V., and Kennedy, P.T. (2024). Editorial: The Current Challenges Underlying Hepatitis D Virus Infection. Front. Med., 10.","DOI":"10.3389\/fmed.2023.1355027"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/jvh.13755","article-title":"Novel Concepts on Mechanisms Underlying Hepatitis Delta Virus Persistence and Related Pathogenesis","volume":"29","author":"Salpini","year":"2022","journal-title":"J. Viral Hepat."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/S1470-2045(25)00403-6","article-title":"Carcinogenicity of Hepatitis D Virus, Human Cytomegalovirus, and Merkel Cell Polyomavirus","volume":"26","author":"Karagas","year":"2025","journal-title":"Lancet Oncol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.12998\/wjcc.v10.i12.3662","article-title":"Pathophysiological Mechanisms of Hepatic Stellate Cells Activation in Liver Fibrosis","volume":"10","author":"Garbuzenko","year":"2022","journal-title":"World J. Clin. Cases"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1111\/liv.15655","article-title":"Hepatitis D Virus Infection, Innate Immune Response and Antiviral Treatments in Stem Cell-Derived Hepatocytes","volume":"43","author":"Lange","year":"2023","journal-title":"Liver Int."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3390\/livers4040040","article-title":"Intrinsic Immune Response of HBV\/HDV-Infected Cells and Corresponding Innate (Like) Immune Cell Activation","volume":"4","author":"Groth","year":"2024","journal-title":"Livers"},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Nishida, A., and Andoh, A. (2025). The Role of Inflammation in Cancer: Mechanisms of Tumor Initiation, Progression, and Metastasis. Cells, 14.","DOI":"10.3390\/cells14070488"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijid.2023.11.005","article-title":"Prevalence of Hepatitis D Virus Infection in Central Italy Has Remained Stable across the Last 2 Decades with Dominance of Subgenotypes 1 and Characterized by Elevated Viral Replication","volume":"138","author":"Salpini","year":"2024","journal-title":"Int. J. Infect. Dis."},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Colagrossi, L., Salpini, R., Scutari, R., Carioti, L., Battisti, A., Piermatteo, L., Bertoli, A., Fabeni, L., Minichini, C., and Trimoulet, P. (2018). HDV Can Constrain HBV Genetic Evolution in HBsAg: Implications for the Identification of Innovative Pharmacological Targets. Viruses, 10.","DOI":"10.3390\/v10070363"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1086\/368389","article-title":"Synergistic Activation of the Serum Response Element-Dependent Pathway by Hepatitis B Virus x Protein and Large-Isoform Hepatitis Delta Antigen","volume":"187","author":"Goto","year":"2003","journal-title":"J. Infect. Dis."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/j.dld.2025.01.022","article-title":"HDV Persistence Acts Independently from HBV Reservoir Extent and Is Sustained by HBsAg Production Mainly Derived from Integrated HBV-DNA","volume":"57","author":"Piermatteo","year":"2025","journal-title":"Dig. Liver Dis."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.dld.2024.01.045","article-title":"Pathways Sustaining HDV Activity Act Independently from the Size of HBV Resevoir and Are Fueled by an Abundant Expression of HBsAg from Integrated HBV-DNA","volume":"56","author":"Salpini","year":"2024","journal-title":"Dig. Liver Dis."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/j.dld.2025.01.153","article-title":"A Peculiar Composition of HBsAg Isoforms Characterizes Chronic HDV Coinfection Respect to HBV Mono-Infection with Higher Middle- and Large-HBs Levels Reflecting a More Intense HDV Activity","volume":"57","author":"Magnapera","year":"2025","journal-title":"Dig. Liver Dis."},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Brancaccio, G., Salpini, R., Piermatteo, L., Surdo, M., Fini, V., Colagrossi, L., Cantone, M., Battisti, A., Oda, Y., and Di Carlo, D. (2021). An Increase in the Levels of Middle Surface Antigen Characterizes Patients Developing HBV-Driven Liver Cancer Despite Prolonged Virological Suppression. Microorganisms, 9.","DOI":"10.3390\/microorganisms9040752"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/j.1365-2443.2007.01094.x","article-title":"Hepatitis Delta Antigen Binds to the Clamp of RNA Polymerase II and Affects Transcriptional Fidelity","volume":"12","author":"Yamaguchi","year":"2007","journal-title":"Genes Cells"},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Smirnova, O.A., Ivanova, O.N., Mukhtarov, F., Valuev-Elliston, V.T., Fedulov, A.P., Rubtsov, P.M., Zakirova, N.F., Kochetkov, S.N., Bartosch, B., and Ivanov, A.V. (2023). Hepatitis Delta Virus Antigens Trigger Oxidative Stress, Activate Antioxidant Nrf2\/ARE Pathway, and Induce Unfolded Protein Response. Antioxidants, 12.","DOI":"10.3390\/antiox12040974"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.18632\/oncotarget.13904","article-title":"Oxidative Stress, a Trigger of Hepatitis C and B Virus-Induced Liver Carcinogenesis","volume":"8","author":"Ivanov","year":"2016","journal-title":"Oncotarget"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.cmi.2016.07.019","article-title":"Molecular Mechanisms of Hepatitis C Virus-Induced Hepatocellular Carcinoma","volume":"22","author":"Vescovo","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"El-Shenawy, R., Farouk, S., Helmy, N., and Din, N.B.E. (2023). Risk Factors Associated with Development of Hepatocellular Carcinoma in Hepatitis C Virus Patients. Hepatitis C\u2014Recent Advances, IntechOpen.","DOI":"10.5772\/intechopen.1001057"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"127","DOI":"10.4103\/jgid.jgid_211_23","article-title":"Coinfection of Hepatitis B and C Viruses and Risk of Hepatocellular Carcinoma: Systematic Review and Meta-Analysis","volume":"16","author":"Awadh","year":"2024","journal-title":"J. Glob. Infect. Dis."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1097\/HEP.0000000000001015","article-title":"Liver Stiffness Progression in Biopsy-Proven Metabolic Dysfunction-Associated Steatotic Disease among People with Diabetes versus People without Diabetes: A Prospective Multicenter Study","volume":"81","author":"Huang","year":"2025","journal-title":"Hepatology"},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Hu, J.L., and Huang, A.L. (2023). Dynamics of Hepatitis B Virus Covalently Closed Circular DNA: A Mini-Review. Microorganisms, 11.","DOI":"10.3390\/microorganisms11030600"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1172\/JCI83339","article-title":"In Situ Analysis of Intrahepatic Virological Events in Chronic Hepatitis B Virus Infection","volume":"126","author":"Zhang","year":"2016","journal-title":"J. Clin. Investig."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"100664","DOI":"10.1016\/j.jhepr.2022.100664","article-title":"Intrahepatic Quantification of HBV Antigens in Chronic Hepatitis B Reveals Heterogeneity and Treatment-Mediated Reductions in HBV Core-Positive Cells","volume":"5","author":"Aggarwal","year":"2023","journal-title":"JHEP Rep."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1053\/j.gastro.2021.12.286","article-title":"Inhibition of Viral Replication Reduces Transcriptionally Active Distinct Hepatitis B Virus Integrations With Implications on Host Gene Dysregulation","volume":"162","author":"Hsu","year":"2022","journal-title":"Gastroenterology"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"E801","DOI":"10.1093\/cid\/ciac383","article-title":"Effect of Antiviral Treatment on Hepatitis B Virus Integration and Hepatocyte Clonal Expansion","volume":"76","author":"Chow","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Moini, M., and Fung, S. (2022). HBsAg Loss as a Treatment Endpoint for Chronic HBV Infection: HBV Cure. Viruses, 14.","DOI":"10.3390\/v14040657"},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Degasperi, E., Anolli, M.P., and Lampertico, P. (2022). Towards a Functional Cure for Hepatitis B Virus: A 2022 Update on New Antiviral Strategies. Viruses, 14.","DOI":"10.3390\/v14112404"},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Mak, L.Y., Seto, W.K., and Yuen, M.F. (2021). Novel Antivirals in Clinical Development for Chronic Hepatitis B Infection. Viruses, 13.","DOI":"10.3390\/v13061169"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3350\/cmh.2022.0012","article-title":"RNA Interference as a Novel Treatment Strategy for Chronic Hepatitis B Infection","volume":"28","author":"Hui","year":"2022","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.14218\/JCTH.2023.00067","article-title":"Novel Approaches to Inhibition of HBsAg Expression from CccDNA and Chromosomal Integrants: A Review","volume":"11","author":"Abdelwahed","year":"2023","journal-title":"J. Clin. Transl. Hepatol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.virs.2023.12.005","article-title":"Classifying Hepatitis B Therapies with Insights from Covalently Closed Circular DNA Dynamics","volume":"39","author":"Hu","year":"2024","journal-title":"Virol. Sin."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"srep43838","DOI":"10.1038\/srep43838","article-title":"Nucleic Acid-Based Polymers Effective against Hepatitis B Virus Infection in Patients Don\u2019t Harbor Immunostimulatory Properties in Primary Isolated Liver Cells","volume":"7","author":"Real","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1053\/j.gastro.2020.02.058","article-title":"Safety and Efficacy of 48 Weeks REP 2139 or REP 2165, Tenofovir Disoproxil, and Pegylated Interferon Alfa-2a in Patients With Chronic HBV Infection Na\u00efve to Nucleos(t)Ide Therapy","volume":"158","author":"Bazinet","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"Vaillant, A. (2022). Oligonucleotide-Based Therapies for Chronic HBV Infection: A Primer on Biochemistry, Mechanisms and Antiviral Effects. Viruses, 14.","DOI":"10.3390\/v14092052"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/s41392-024-01871-8","article-title":"Optimized RNA Interference Therapeutics Combined with Interleukin-2 MRNA for Treating Hepatitis B Virus Infection","volume":"9","author":"Zai","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"eadv3678","DOI":"10.1126\/scitranslmed.adv3678","article-title":"Targeting HBV with RNA Interference: Paths to Cure","volume":"17","author":"Iannacone","year":"2025","journal-title":"Sci. Transl. Med."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.jhep.2023.05.023","article-title":"Evaluation of RNAi Therapeutics VIR-2218 and ALN-HBV for Chronic Hepatitis B: Results from Randomized Clinical Trials","volume":"79","author":"Gane","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S2468-1253(23)00148-6","article-title":"Efficacy and Safety of the SiRNA JNJ-73763989 and the Capsid Assembly Modulator JNJ-56136379 (Bersacapavir) with Nucleos(t)Ide Analogues for the Treatment of Chronic Hepatitis B Virus Infection (REEF-1): A Multicentre, Double-Blind, Active-Controlled, Randomised, Phase 2b Trial","volume":"8","author":"Yuen","year":"2023","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.jhep.2023.07.026","article-title":"First-in-Human Randomized Study of RNAi Therapeutic RG6346 for Chronic Hepatitis B Virus Infection","volume":"79","author":"Gane","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S2468-1253(24)00237-1","article-title":"VIR-2218 (Elebsiran) plus Pegylated Interferon-Alfa-2a in Participants with Chronic Hepatitis B Virus Infection: A Phase 2 Study","volume":"9","author":"Yuen","year":"2024","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_168","doi-asserted-by":"crossref","unstructured":"Collotta, D., Bertocchi, I., Chiapello, E., and Collino, M. (2023). Antisense Oligonucleotides: A Novel Frontier in Pharmacological Strategy. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1304342"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1080\/13543784.2023.2277389","article-title":"Bepirovirsen (GSK3228836) in Chronic Hepatitis B Infection: An Evaluation of Phase II Progress","volume":"32","author":"Mak","year":"2023","journal-title":"Expert. Opin. Investig. Drugs"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1056\/NEJMoa2210027","article-title":"Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection","volume":"387","author":"Yuen","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1002\/hep.31920","article-title":"Clinical Study of Single-Stranded Oligonucleotide RO7062931 in Healthy Volunteers and Patients With Chronic Hepatitis B","volume":"74","author":"Gane","year":"2021","journal-title":"Hepatology"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"10619","DOI":"10.1021\/acs.jmedchem.8b01245","article-title":"Discovery of RG7834: The First-in-Class Selective and Orally Available Small Molecule Hepatitis B Virus Expression Inhibitor with Novel Mechanism of Action","volume":"61","author":"Han","year":"2018","journal-title":"J. Med. Chem."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"128977","DOI":"10.1016\/j.bmcl.2022.128977","article-title":"Discovery and Preclinical Evaluations of GST-HG131, a Novel HBV Antigen Inhibitor for the Treatment of Chronic Hepatitis B Infection","volume":"75","author":"Hu","year":"2022","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s40164-025-00642-7","article-title":"Hepatitis B Surface Antigen: Carcinogenesis Mechanisms and Clinical Implications in Hepatocellular Carcinoma","volume":"14","author":"Hao","year":"2025","journal-title":"Exp. Hematol. Oncol."},{"key":"ref_175","doi-asserted-by":"crossref","unstructured":"Harrison, E.B., Dulmage, K., Evans, K., Grimason, H., Heard, N., Aseyiga, A., Lewis, W.E., Morris, B., Mukherjee, A., and Reddick, T. (2024, January 5\u20138). Preclinical Safety Data for PBGENE-HBV Gene Editing Program Supports Advancement to Clinical Trials as a Potentially Curative Treatment for Chronic Hepatitis B. Proceedings of the European Association for the Study of the Liver Congress, Milan, Italy.","DOI":"10.1016\/S0168-8278(24)00589-0"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1016\/j.ymthe.2022.05.013","article-title":"Targeting the hepatitis B cccDNA with a sequence-specific ARCUS nuclease to eliminate hepatitis B virus in vivo","volume":"30","author":"Gorsuch","year":"2022","journal-title":"Mol Ther."},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"Taverniti, V., Ligat, G., Debing, Y., Kum, D.B., Baumert, T.F., and Verrier, E.R. (2022). Capsid Assembly Modulators as Antiviral Agents against HBV: Molecular Mechanisms and Clinical Perspectives. J. Clin. Med., 11.","DOI":"10.3390\/jcm11051349"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41467-023-36219-3","article-title":"Molecular Elucidation of Drug-Induced Abnormal Assemblies of the Hepatitis B Virus Capsid Protein by Solid-State NMR","volume":"14","author":"Lecoq","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_179","doi-asserted-by":"crossref","unstructured":"Kim, H., Ko, C., Lee, J.Y., and Kim, M. (2021). Current Progress in the Development of Hepatitis B Virus Capsid Assembly Modulators: Chemical Structure, Mode-of-Action and Efficacy. Molecules, 26.","DOI":"10.3390\/molecules26247420"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S2468-1253(21)00256-9","article-title":"The Potential Immune Regulation Benefit of CpAMs beyond HBV Suppression","volume":"6","author":"Wu","year":"2021","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S2468-1253(21)00176-X","article-title":"Safety, Pharmacokinetics, and Antiviral Activity of RO7049389, a Core Protein Allosteric Modulator, in Patients with Chronic Hepatitis B Virus Infection: A Multicentre, Randomised, Placebo-Controlled, Phase 1 Trial","volume":"6","author":"Yuen","year":"2021","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1053\/j.gastro.2020.04.036","article-title":"JNJ-56136379, an HBV Capsid Assembly Modulator, Is Well-Tolerated and Has Antiviral Activity in a Phase 1 Study of Patients With Chronic Infection","volume":"159","author":"Zoulim","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"106446","DOI":"10.1016\/j.jinf.2025.106446","article-title":"Efficacy and Safety of GLS4 with Entecavir vs Entecavir Alone in Chronic Hepatitis B Patients: A Multicenter Clinical Trial","volume":"90","author":"Zhang","year":"2025","journal-title":"J. Infect."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jhep.2022.04.005","article-title":"Safety and Efficacy of Vebicorvir in Virologically Suppressed Patients with Chronic Hepatitis B Virus Infection","volume":"77","author":"Yuen","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"267","DOI":"10.36519\/idcm.2023.265","article-title":"New Treatment Options in Chronic Hepatitis B: How Close Are We to Cure?","volume":"5","author":"Korkmaz","year":"2023","journal-title":"Infect. Dis. Clin. Microbiol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.jhep.2016.05.016","article-title":"Randomized Phase II Study of GS-4774 as a Therapeutic Vaccine in Virally Suppressed Patients with Chronic Hepatitis B","volume":"65","author":"Lok","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"e1232","DOI":"10.1002\/cti2.1232","article-title":"Designing the Next-Generation Therapeutic Vaccines to Cure Chronic Hepatitis B: Focus on Antigen Presentation, Vaccine Properties and Effect Measures","volume":"10","author":"Jansen","year":"2021","journal-title":"Clin. Transl. Immunol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.jhep.2019.06.028","article-title":"Anti-PD-1 Blockade with Nivolumab with and without Therapeutic Vaccination for Virally Suppressed Chronic Hepatitis B: A Pilot Study","volume":"71","author":"Gane","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1111\/jvh.12942","article-title":"Safety and Efficacy of Vesatolimod (GS-9620) in Patients with Chronic Hepatitis B Who Are Not Currently on Antiviral Treatment","volume":"25","author":"Agarwal","year":"2018","journal-title":"J. Viral Hepat."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"100975","DOI":"10.1016\/j.jhepr.2023.100975","article-title":"Safety, Pharmacodynamics, and Antiviral Activity of Selgantolimod in Viremic Patients with Chronic Hepatitis B Virus Infection","volume":"6","author":"Janssen","year":"2023","journal-title":"JHEP Rep."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.exppara.2009.07.005","article-title":"Cryptosporidium and Giardia: Treatment Options and Prospects for New Drugs","volume":"124","author":"Rossignol","year":"2010","journal-title":"Exp. Parasitol."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1086\/428839","article-title":"Nitazoxanide: A New Thiazolide Antiparasitic Agent","volume":"40","author":"Fox","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1128\/AAC.40.10.2266","article-title":"In Vitro Evaluation of Activities of Nitazoxanide and Tizoxanide against Anaerobes and Aerobic Organisms","volume":"40","author":"Dubreuil","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3109\/00016488309130929","article-title":"Effects of Drainage in the Treatment of Acute Maxillary Sinusitis","volume":"95","author":"Engquist","year":"1983","journal-title":"Acta Otolaryngol."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"100353","DOI":"10.1016\/j.jve.2023.100353","article-title":"Antiviral Activity of Nitazoxanide against Morbillivirus Infections","volume":"9","author":"Stelitano","year":"2023","journal-title":"J. Virus Erad."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"10425","DOI":"10.1038\/s41598-018-28172-9","article-title":"Nitazoxanide Inhibits Paramyxovirus Replication by Targeting the Fusion Protein Folding: Role of Glycoprotein-Specific Thiol Oxidoreductase ERp57","volume":"8","author":"Piacentini","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_197","doi-asserted-by":"crossref","unstructured":"Piacentini, S., Riccio, A., Santopolo, S., Pauciullo, S., La Frazia, S., Rossi, A., Rossignol, J.F., and Santoro, M.G. (2023). The FDA-Approved Drug Nitazoxanide Is a Potent Inhibitor of Human Seasonal Coronaviruses Acting at Postentry Level: Effect on the Viral Spike Glycoprotein. Front. Microbiol., 14.","DOI":"10.3389\/fmicb.2023.1206951"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.antiviral.2018.06.008","article-title":"The Second-Generation Thiazolide Haloxanide Is a Potent Inhibitor of Avian Influenza Virus Replication","volume":"157","author":"Piacentini","year":"2018","journal-title":"Antivir. Res."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"11096","DOI":"10.1128\/JVI.01213-13","article-title":"Thiazolides, a New Class of Antiviral Agents Effective against Rotavirus Infection, Target Viral Morphogenesis, Inhibiting Viroplasm Formation","volume":"87","author":"Ciucci","year":"2013","journal-title":"J. Virol."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jcmgh.2018.10.010","article-title":"Inhibition of HBV Transcription from CccDNA with Nitazoxanide by Targeting the HBx-DDB1 Interaction","volume":"7","author":"Sekiba","year":"2019","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.antiviral.2014.07.014","article-title":"Nitazoxanide: A First-in-Class Broad-Spectrum Antiviral Agent","volume":"110","author":"Rossignol","year":"2014","journal-title":"Antivir. Res."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/hep4.1339","article-title":"A Pilot Clinical Trial of Nitazoxanide in the Treatment of Chronic Hepatitis B","volume":"3","author":"Rossignol","year":"2019","journal-title":"Hepatol. Commun."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/jvh.13811","article-title":"Bulevirtide-Based Treatment Strategies for Chronic Hepatitis Delta: A Review","volume":"30","author":"Degasperi","year":"2023","journal-title":"J. Viral Hepat."},{"key":"ref_204","unstructured":"(2025, August 01). Hepatitis. Available online: https:\/\/www.who.int\/data\/gho\/data\/themes\/chronic-viral-hepatitis?utm_source=chatgpt.com."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"2219347","DOI":"10.1080\/22221751.2023.2219347","article-title":"Unexpected Rise in the Circulation of Complex HBV Variants Enriched of HBsAg Vaccine-Escape Mutations in HBV Genotype-D: Potential Impact on HBsAg Detection\/Quantification and Vaccination Strategies","volume":"12","author":"Piermatteo","year":"2023","journal-title":"Emerg. Microbes Infect."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/18\/2\/185\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T05:32:14Z","timestamp":1770787934000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/18\/2\/185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":205,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["v18020185"],"URL":"https:\/\/doi.org\/10.3390\/v18020185","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,29]]}}}